Outpatient Surgery Magazine

Game Changers in Surgery - June 2019 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/1133356

Contents of this Issue

Navigation

Page 12 of 27

*Dantrium ® IV has 36 month shelf life from date of manufacturing. There is always some lag period between manufacturing date and when the product ships to the end user, which varies when the order is placed. † Cost savings are based on MHAUS recommendation of storing 36 Dantrium ® IV vials compared with an equivalent dose of competitor products, using Dec 2017 WAC price per vial. Please see accompanying Prescribing Information For more information on Dantrium ® IV please visit www.parsterileproducts.com. Dantrium ® is a registered trademark of Par Pharmaceutical, Inc. © 2017 PSPB01 1217 To order Dantrium ® IV from Par Sterile Products, LLC, call 800-828-9393 and select option 6 or email dantriumcustomerorders@parpharm.com. Shelf Life 36-month shelf life* may result in more time between required re-orders. Cost-Competitive Pricing Priced comparatively to competitor products † Emergency orders Dantrium ® IV is available for emergency orders and can be ordered: s AS DROP SHIP s AS DIRECT PURCHASE s THROUGH LOCAL WHOLESALERS AND DISTRIBUTORS DANTRIUM ® IV (dantrolene sodium for injection) from Par Sterile Products, LLC Important Safety information Management of Malignant Hyperthermia (MH) crises requires various supportive measures individualized for the patient's condition. Administration of Dantrium ® IV is one component of therapy and should not be considered a substitute for these measures. Even when properly treated, an MH crisis can result in death. Adverse events with Dantrium ® IV include loss of grip strength, weakness in the legs, drowsiness, dizziness, thrombophlebitis, and tissue necrosis/injection site reactions secondary to extravasation. There have been rare reports of pulmonary edema, urticaria and erythema.

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Game Changers in Surgery - June 2019 - Subscribe to Outpatient Surgery Magazine